awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33402372-53D20757-2A2F-438A-B563-528418B72B88
Q33402372-53D20757-2A2F-438A-B563-528418B72B88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33402372-53D20757-2A2F-438A-B563-528418B72B88
Thrombotic microangiopathy and associated renal disorders.
P2860
Q33402372-53D20757-2A2F-438A-B563-528418B72B88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33402372-53D20757-2A2F-438A-B563-528418B72B88
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
790e6bab030cfd70e8de9c05b5ea59f4dea3b26e
P2860
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.